Funding for science in Brazil is suffering due to the country’s economy and debt. The projected 2015 budgets of the Ministry of Science and the Ministry of Education, which funds graduate students, have been cut 25% from BRL 7.3 billion ($2 billion) and 9% from BRL 48.8 billion, respectively. The cuts are a result of […]
The European Commission has released information about Horizon 2020’s first 100 calls for proposals, which closed on December 1, 2014. For these calls, 31,115 full, eligible proposals were submitted. Applications from those proposals numbered 123,334 and together requested €80.3 billion ($88.5 billion). Of the proposals, 4,315 were retained for funding, and 3,236 grant agreements were […]
With this month’s approval by the European Council of Ministers and Greece’s parliament of the most recent plan to bail out the country, prospects for Greece’s research budgets are improving. Since the Greek financial crisis began, researchers were dependent on international funds, such as Horizon 2020, to support their projects. Now, some money from the […]
This month, India’s Cabinet Committee on Economic Affairs approved an INR 1,750 crore ($272 million) proposal to strengthen and upgrade the central and state drug regulatory systems over a three-year period. The central structures, which include the Central Drug Standards Organization (CDSCO), will receive INR 900 crore, and the state governments, after signing a memorandum […]
Central European countries spend less than 1% of GDP on R&D, besides Slovenia, which spends 2.6%. But a survey of 411 firms from 11 Central European countries (Bulgaria, Croatia, the Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, Romania, Slovakia and Slovenia) revealed that companies in the region as a whole plan to increase their short- […]
R&D is on the rise in China, as the country attracted $5.5 billion in 88 foreign greenfield R&D projects from 2010 to 2014, according to fDi Markets. This places China at the top globally in amount invested in such projects, and second in number of projects to the US, which had 91. The pharmaceuticals, business […]
An assessment of 265 biopharmaceutical facilities in the 35 countries comprising the Europe, the Middle East and Africa (EMEA) region found that the combined production of the sites in 2014 was more than 2.4 million L. Among the sites, 26%, 18%, 15% manufactured recombinant proteins only, vaccines only, or “other” (excluding mAbs and blood processing), […]
The UK government’s expenditures on science, engineering and technology (SET) in 2013 were £10.9 billion ($17.0 billion), an increase of 9%. In constant prices, the increase was 7%. SET spending accounted for 0.64% of GDP in 2013. Research Councils spent 33% of the total, followed by civil departments and Higher Education Funding Councils, at 25% […]
With oil prices dropping along with the industry’s slow or even negative growth, Latin America’s 2015 tax revenues from oil exploration production and processing are expected to fall overall, declining by 1.0%–1.5% of GDP for Bolivia, Ecuador and Mexico. Revenues from Colombia and Peru’s oil industries are also forecast to decline. The region has not […]
The European Commission agreed this month to increase funds for InnovFin, the program supporting research projects considered to be high risk and that might otherwise not receive financial backing. The €750 million ($815 million) in funds through the European Investment Bank and European Investment Fund would be used to increase the availability of loan guarantees […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
